Tag: blindness
-
March 2025 Medical Article About Blindness or Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
Discusses Timing for Increased Risk of Semaglutide-related Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Side Effect (Posted by Tom Lamb at Drug Injury Watch) On March 27, 2025, the JAMA Ophthalmology medical journal published a report…
-
Novo Nordisk Semaglutide Drug Ozempic Linked to Vision Loss, Doubling the Risk: December 2024 Update
European Drug Regulators Are Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU…
-
Syfovre Injections Side Effects Legal Compensation Cases Being Filed for Patients
Drug Company Apellis Failed to Warn About Retinal Vasculitis Until a November 2023 Label Change (Posted by Tom Lamb at Drug Injury Watch) We are handling Syfovre injections side effects legal compensation cases being filed…
-
Wegovy, Rybelsus, and Ozempic Eye Side Effects: Semaglutide Linked to NAION
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or "Eye Stroke", Can Cause Vision Loss (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent findings that…
-
Syfovre Safety-Benefit Assessment by Europe’s Drug Regulator Differs From FDA
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment…
-
Syfovre Retinal Vaso-occlusive Vasculitis Case Report Involving 78-year Old Woman With Vision Loss
She Went to the Local ER With Loss of Vision 11 Days After Receiving an Intravitreal Syfovre (Pegcetacoplan) Injection (Posted by Tom Lamb at Drug Injury Watch) In the March 2024 edition of the American…
-
Syfovre Update: New Warnings About Retinal Vasculitis and/or Retinal Vascular Occlusion After Syfovre Injections
November 2023 Syfovre Label Change Comes After Earlier Reports of Eye Inflammation and Severe Vision Loss (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites…
-
Syfovre Patients Eye Side Effects Cases at Iowa Clinic: Important 2023 AAO Meeting Presentation
A Syfovre Case of Hemorrhagic Occlusive Vasculitis-type Inflammation With Continued Blindness Is Reported (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current challenges with…
-
Eye Drug Syfovre Side Effects: Occlusive Retinal Vasculitis, Eye Inflammation, Vision Loss, And Blindness
American Society of Retinal Specialists (ASRS) July 2023 Warning Letter About Adverse Events Reports Associated With Syfovre (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis…
-
Beovu Vision Loss Lawsuits Involve Serious Eye Problems Due to Beovu Injections Reactions
People Need to Know Beovu Lawsuits Are Filed as Individual Cases; No Beovu Class Actions for Beovu Eye Problems (Posted by Tom Lamb at Drug Injury Watch) Starting in January 2021 Beovu…